Accenture announces collaboration with Bayer to streamline drug development processes through INTIENT Clinical platform
Accenture has announced a collaboration with Bayer to implement the Accenture INTIENT Clinical platform to help simplify and speed its drug development processes.
Accenture introduces INTIENT™, an innovative platform to advance the discovery, development and delivery of patient treatments
The INTIENT platform vastly improves the continuity and flow of data across life sciences enterprises, supporting the delivery of ground-breaking treatments for patients.